SELPLG and neoplasm: This system was also tested in vivo, where a protein G-modified virus retargeted with a chimeric P-selectin Glycoprotein Ligand-1 (PSGL-1)-Fc fusion protein was injected i.v. to target tumour-associated vasculature in tumour-bearing mice.